NCT00491179
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Clinical trial condition
Hepatitis
Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.
2,967 public trials
189 recruiting studies
Hepatitis trial results
Completed
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients
NCT00255177
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
- University of Connecticut Farmington, Connecticut, United States
- Orlando Clinical Research Center Orlando, Florida, United States
- Saint Louis University St Louis, Missouri, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
NCT00324961
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Wuhan, Hubei, China
- GSK Investigational Site Nanjing, Jiangsu, China
NCT00863785
- Conditions
- Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Hepatitis, +10 more
- Locations
-
- Centre Hospitalier d'Abbeville Abbeville, France
- Centre Hospitalier Beauvais Beauvais, France
- Centre Hospitalier Universitaire de Besançon Besançon, France
- Centre Hospitalier Universitaire de Caen Caen, France
NCT00358696
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
- Locations
-
- Pender Community Health Centre Vancouver, British Columbia, Canada
Completed
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients
NCT00441974
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Wuhan, Hubei, China
- GSK Investigational Site Nanjing, Jiangsu, China
NCT00247884
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
- Pender Community Health Centre Vancouver, British Columbia, Canada
- Cool-Aid Community Health Centre Victoria, British Columbia, Canada
Completed
Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection
NCT00565539
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Northwestern Memorial Hospital Chicago, Illinois, United States
- Henry Ford Health System Detroit, Michigan, United States
- Mayo Clinic Rochester, Minnesota, United States
- University Hospital (UMDNJ) Newark, New Jersey, United States
NCT00316719
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
Not specified
NCT00792610
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan